rethinkPeptides Search
Menu
Research citation

Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.

Diabetes spectrum : a publication of the American Diabetes Association, 28(4), 283-8

Citation

Jones, S Christopher; Ryan, Debra L; Pratt, Valerie S W; Niak, Ali; Brinker, Allen D. (2015). Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.. Diabetes spectrum : a publication of the American Diabetes Association, 28(4), 283-8. https://doi.org/10.2337/diaspect.28.4.283